Detalhe da pesquisa
1.
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Haematologica
; 105(9): 2262-2272, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054051
2.
[Glucocorticoid-induced diabetes and risk factors during high-dose therapy].
Ugeskr Laeger
; 180(18)2018 Apr 30.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-29720341